Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where R.S. Accolla is active.

Publication


Featured researches published by R.S. Accolla.


European Journal of Immunology | 1998

Double‐stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II‐mediated antigen presentation

Gilberto Filaci; Paola Contini; Iolanda Grasso; Donatella Bignardi; Massimo Ghio; Lorella Lanza; Marco Scudeletti; Francesco Puppo; Martino Bolognesi; R.S. Accolla; Francesco Indiveri

CD4+ T cells proliferating in response to purified double‐stranded deoxyribonucleic acid (dsDNA) have been recently demonstrated in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Their activation was inhibited by anti‐HLA class II (HLA‐II) monoclonal antibodies; thus, the existence of a molecular interaction between dsDNA and HLA‐II is conceivable. In this report we show that dsDNA specifically bind to HLA‐II. After preincubating cells with purified dsDNA or synthetic oligonucleotides, dsDNA was detected on the cell membrane and in the lysates of HLA‐II+ but not of isogenic HLA‐II− cell lines. We demonstrate that dsDNA binding inhibits that of a specific peptide to HLA‐II. Mixed lymphocyte reaction and antigen‐specific T cell proliferation were inhibited by the preincubation of stimulator cells or antigen‐presenting cells with dsDNA. These results suggest the existence of a novel mechanism of down‐modulation of the CD4+ T cell function generated by lack of stimulation due to the HLA‐II presenting molecules being “n;‐occupied” by dsDNA.


European Journal of Immunology | 1996

Active suppression of the class II transactivator‐encoding AIR‐1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells

Silvia Sartoris; Giovanna Tosi; Andrea De Lerma Barbaro; Tiziana Cestari; R.S. Accolla


Journal of Immunology | 1994

Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.

A De Lerma Barbaro; Silvia Sartoris; Giovanna Tosi; Morena Nicolis; R.S. Accolla


European Journal of Immunology | 2009

Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.

Enrica Balza; Barbara Carnemolla; Lorenzo Mortara; Patrizia Castellani; D. Soncini; R.S. Accolla; Laura Borsi


51th Annual Meeting of the Italian Cancer Society (SIC). | 2009

Non-replicating MHC Class II- CIITA-positive mammary adenocarcinoma cells act as an effective anti-tumor-preventive vaccine by inducing long-lasting tumor-specific CD8+ T cells and potent CD4+ T helper cells.

Lorenzo Mortara; Valeria Frangione; Patrizia Castellani; A. De Lerma Barbaro; R.S. Accolla


Union International Contre le Cancer (UICC). | 2008

Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.

Lorenzo Mortara; Enrica Balza; Francesca Sassi; Patrizia Castellani; Barbara Carnemolla; A. De Lerma Barbaro; Sara Fossati; Giovanna Tosi; R.S. Accolla; Laura Borsi


European Journal of Immunology | 2008

Tumor rejection and anti-tumor memory to cancer cells of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.

Valeria Frangione; Lorenzo Mortara; Patrizia Castellani; A. De Lerma Barbaro; R.S. Accolla


Congrès Annuel de la SFI. | 2008

The immunological basis of tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA-driven autologous MHC class II genes.

Valeria Frangione; Lorenzo Mortara; A. De Lerma Barbaro; R.S. Accolla


Minerva Medica | 2007

The immunological basis of therapy-induced antitumor vaccination by targeting Tumor Necrosis Factor a to tumor vessels in combination with melphalan

Lorenzo Mortara; Enrica Balza; Francesca Sassi; Patrizia Castellani; Barbara Carnemolla; A. De Lerma Barbaro; Sara Fossati; Giovanna Tosi; R.S. Accolla


13th International Congress of Immunology | 2007

Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan

R.S. Accolla; Lorenzo Mortara; Enrica Balza; Francesca Sassi; Patrizia Castellani; Barbara Carnemolla; A. De Lerma Barbaro; Giovanna Tosi; Laura Borsi

Collaboration


Dive into the R.S. Accolla's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. D'Agostino

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar

Patrizia Castellani

National Cancer Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge